4//SEC Filing
Mahaney Paige 4
Accession 0001193125-25-258664
CIK 0001662579other
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 4:30 PM ET
Size
6.4 KB
Accession
0001193125-25-258664
Insider Transaction Report
Form 4
Mahaney Paige
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2025-10-28$2.58/sh−5,644$14,562→ 99,356 total - Exercise/Conversion
Common Stock
2025-10-28+19,200→ 105,000 total
Footnotes (2)
- [F1]Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on October 28, 2024.
- [F2]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0002040313
Filing Metadata
- Form type
- 4
- Filed
- Oct 29, 8:00 PM ET
- Accepted
- Oct 30, 4:30 PM ET
- Size
- 6.4 KB